How do I implement pathogen reduced Cryoprecipitated fibrinogen complex in a tertiary Hospital's blood Bank
Transfusion · 2024
DOI: 10.1111/trf.17940 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transfusion, 2024. Verfasst von Jennifer Aidikoff und 3 weiteren Autor:innen. Beteiligte Einrichtung: Kaiser-Permanente, Los Angeles Medical Center, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Fibrinogen, Tertiary Care Centers, Blood Banks. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
Background
Kaiser‐Permanente Los Angeles Medical Center (LAMC) is a 560 licensed bed facility that provides regional cardiovascular services, including 1200 open heart surgeries annually. In 2021, LAMC explored alternative therapies to offset the impact of pandemic‐driven cryo AHF shortages, and implemented Pathogen Reduced Cryoprecipitated Fibrinogen Complex (also known as INTERCEPT Fibrinogen Complex or IFC). IFC is approved to treat and control bleeding associated with fibrinogen deficiency. Unlike cryo AHF, IFC has 5‐day post‐thaw shelf life with potential operational and clinical benefits. The implementation steps and the operational advantages to the LAMC Blood Bank are described. Study Design and Methods Eighteen months post‐implementation, the institution reviewed their product implementation experience and compared IFC with cryo AHF with a retrospective review of transfusion service and cardiac post‐op data.
Results
IFC significantly decreased product wastage rates and order‐to‐issue time. It did not significantly impact post‐op product utilization or hospital length of stay (LOS) in cardiac surgery patients when compared with cryo AHF.
Discussion
Implementation of IFC provides improved product supply stability, shorter turnaround times, and reduced wastage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kaiser-Permanente, Los Angeles Medical Center, Los Angeles, California, USA.
- Department of Cardiac Surgery, Southern California Permanente Medical Group, Los Angeles, California, USA.
- Department of Business Intelligence, Kaiser-Permanente, Los Angeles Medical Center, Los Angeles, California, USA.
- Department of Pathology, Southern California Permanente Medical Group, Los Angeles, California, USA.
- Department of Clinical Science or Health Systems, Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, California, USA.
ORCID-Profile: Hedyeh Shafi
Zitieren
APA
Aidikoff, J., Trivedi, D., Kwock, R., & Shafi, H. (2024). How do I implement pathogen reduced Cryoprecipitated fibrinogen complex in a tertiary Hospital's blood Bank. Transfusion. https://doi.org/10.1111/trf.17940
Vancouver
Aidikoff J, Trivedi D, Kwock R, Shafi H. How do I implement pathogen reduced Cryoprecipitated fibrinogen complex in a tertiary Hospital's blood Bank. Transfusion. 2024. doi:10.1111/trf.17940
BibTeX
@article{Aidikoff2024,
author = {Aidikoff, Jennifer and Trivedi, Dhaval and Kwock, Richard and Shafi, Hedyeh},
title = {How do I implement pathogen reduced Cryoprecipitated fibrinogen complex in a tertiary Hospital's blood Bank},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.17940}
}
EUVIMED